+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

VRAYLAR, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VRAYLAR, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Major Depressive Disorder - Epidemiology Forecast - 2032 - Product Thumbnail Image

Major Depressive Disorder - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 148 Pages
  • Global
From
Gender dysphoria - Epidemiology Insight - 2032 - Product Thumbnail Image

Gender dysphoria - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ganaxolone - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Ganaxolone - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Psychedelic Drugs: Global Market Outlook - Product Thumbnail Image

Psychedelic Drugs: Global Market Outlook

  • Report
  • April 2023
  • 35 Pages
  • Global
From
Postpartum Depression Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Postpartum Depression Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Major Depressive Disorder Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Major Depressive Disorder Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Anorexia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Anorexia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Treatment Resistant Depression Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Treatment Resistant Depression Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
Generalized Anxiety Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Generalized Anxiety Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sigma-1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Sigma-1 Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Schizoaffective Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2025 - Product Thumbnail Image

Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more